Cardiovascular imaging: what have we learned from animal models? by Santos, Arnoldo et al.
REVIEW
published: 21 October 2015
doi: 10.3389/fphar.2015.00227
Frontiers in Pharmacology | www.frontiersin.org 1 October 2015 | Volume 6 | Article 227
Edited by:
Nicolau Beckmann,












This article was submitted to
Experimental Pharmacology and Drug
Discovery,
a section of the journal
Frontiers in Pharmacology
Received: 30 June 2015
Accepted: 22 September 2015
Published: 21 October 2015
Citation:
Santos A, Fernández-Friera L,
Villalba M, López-Melgar B, España S,
Mateo J, Mota RA,
Jiménez-Borreguero J and
Ruiz-Cabello J (2015) Cardiovascular




Cardiovascular imaging: what have
we learned from animal models?
Arnoldo Santos 1, 2, 3, 4, Leticia Fernández-Friera 1, 5, María Villalba 1, Beatriz López-Melgar 1, 5,
Samuel España 1, 2, 3, Jesús Mateo 1, 2, Ruben A. Mota 1, 6, Jesús Jiménez-Borreguero 1, 7 and
Jesús Ruiz-Cabello 1, 2, 8*
1Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain, 2CIBER de Enfermedades Respiratorias
(CIBERES), Madrid, Spain, 3Madrid-MIT M+Visión Consortium, Madrid, Spain, 4Department of Anesthesia, Massachusetts
General Hospital, Harvard Medical School, Boston, MA, USA, 5Hospital Universitario HM Monteprincipe, Madrid, Spain,
6Charles River, Barcelona, Spain, 7Cardiac Imaging Department, Hospital de La Princesa, Madrid, Spain, 8Universidad
Complutense de Madrid, Madrid, Spain
Cardiovascular imaging has become an indispensable tool for patient diagnosis and
follow up. Probably the wide clinical applications of imaging are due to the possibility
of a detailed and high quality description and quantification of cardiovascular system
structure and function. Also phenomena that involve complex physiological mechanisms
and biochemical pathways, such as inflammation and ischemia, can be visualized in
a non-destructive way. The widespread use and evolution of imaging would not have
been possible without animal studies. Animal models have allowed for instance, (i) the
technical development of different imaging tools, (ii) to test hypothesis generated from
human studies and finally, (iii) to evaluate the translational relevance assessment of in vitro
and ex-vivo results. In this review, we will critically describe the contribution of animal
models to the use of biomedical imaging in cardiovascular medicine. We will discuss the
characteristics of the most frequent models used in/for imaging studies. We will cover
the major findings of animal studies focused in the cardiovascular use of the repeatedly
used imaging techniques in clinical practice and experimental studies. We will also
describe the physiological findings and/or learning processes for imaging applications
coming from models of the most common cardiovascular diseases. In these diseases,
imaging research using animals has allowed the study of aspects such as: ventricular
size, shape, global function, and wall thickening, local myocardial function, myocardial
perfusion, metabolism and energetic assessment, infarct quantification, vascular lesion
characterization, myocardial fiber structure, and myocardial calcium uptake. Finally we
will discuss the limitations and future of imaging research with animal models.
Keywords: animal models, biomedical imaging, heart failure, myocardial infarction, pulmonary hypertension,
atherosclerosis
Introduction
Cardiovascular disease is the most important cause of mortality in the Western world. It is
also responsible for a huge lost in years of healthy life and one of the principal reasons for
hospitalizations and emergency room visits. Its epidemiological importance justifies the huge
amount of both clinical and experimental research existing in this area. Such research has allowed
outstanding therapeutic changes, with impact on patient outcomes. However, not only therapy has
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improved the outcomes of patients; diagnosis and monitoring
tools have improved a lot in recent years. Between these
diagnostic tools a special place is reserved for biomedical
imaging. Diagnosis, monitoring, follow-up, and research in
cardiovascular patients are possible using different imaging
techniques.
Using imaging, anatomical, molecular, and functional
evaluation is possible in a complete non-invasive way. The
progress in cardiovascular patient care has benefited from a
rapidly evolving imaging acquisition technique. In the same way
imaging would not have developed without the use of animal
models. Animal, in vitro and ex-vivomodels are useful for testing
hypotheses derived from the clinical setting. They also provide
us a scenario in which to evaluate a new imaging tool or tracer.
In this review we will discuss the principal animal models used
in imaging studies of major cardiovascular diseases.
Characteristics of Animal Models For in
vivo Cardiovascular Imaging Studies
Cardiovascular physiology and diseases are based on the
interaction of multiple genes, metabolic processes and the
environment, increasing significantly their complexity. These
circumstances make highly complicated the full replacement of
in vivo models by simulated in vitro or in silico ones. Therefore,
animal models for cardiovascular research are pivotal for
testing mechanistic hypothesis and for translational research,
including the assessment of pharmacological interventions and
the development of imaging technologies and surgical devices. In
specificfieldsasdrugdevelopment imagingtechniquesapplication
allows to evaluate aspects as target validation, biodistribution,
target interaction, pharmacodynamics, and toxicology. Non-
invasive, imaging techniques allow multiple measurements to
be obtained from a single animal in longitudinal studies. In this
way imaging techniques generate significant outcomes using
smaller and more efficient experimental designs. This can help
to accomplish with the Reduce, Refine and Replace principles
in preclinical development processes including experiments
with animals. However, the animal model itself is important
also in this regard. The selection of the adequate species and
covering important aspects as animal manipulation are critical
for preclinical drug development success.
Selection of the Adequate Animal Model
The correct selection of the animal model of cardiovascular
research is a great challenge. Bibliography describes plenty of
models that mimic the most frequent cardiovascular illnesses.
However, in many cases, the authors do not perform a correct
comparative anatomy study and the findings do not correlate
in the same way that in humans. This issue is especially
important for biomedical imaging in which the goal is to
identify the aspects that directly interacts or modifies specific
anatomical structures. The relative geometry of the heart of
each species, the characteristic features of vasculature, muscle
mass and conduction system are the main anatomical differences
with humans (Hasenfuss, 1998; Hill and Iaizzo, 2009). The
choice of the desired model should be made on grounds of
etiological induction, animal availability, technological disposal
for the species, housing conditions, costs, biological level of
study, quality, and quantity of the data, relevance for the human
condition and ethical sensitivity (Power and Tonkin, 1999;
Hearse and Sutherland, 2000).
Rodents and Other Small Mammals
The laboratory mouse is essential in the study of the
cardiovascular system. The short gestation period and the low
cost of breeding and housing are the main advantages of this
species. The knowledge of its genome, the ability to modify it
and the rapid data acquisition of genomic modification make
attractive the use of mice for studying diverse mechanisms that
are affected during the development of cardiovascular diseases
(Doevendans et al., 1995, 1998; Bostick et al., 2011). Advances
in laboratory animal technology have allowed the miniaturizing
acquisition of murine cardiovascular physiology and diagnostic
images that define, in a sequential way, the progress of the
cardiac illness. However, the mouse shows some obstacles for
extrapolation of any outcome of cardiac disease models. Other
than animal size and beat (400–600), mouse heart differs from
human by: (1) the direct drainage of persistent left superior cava
vein into the right atrium; (2) a single opening of the pulmonary
vein in the left atrium (Webb et al., 1996; Hoyt et al., 2006); (3)
sinoatrial node localization above the junction of right atrium
with the cava vein (Meijler, 1985; Hoyt et al., 2006); (4) helicoidal
distribution of myocardial fibers (McLean and Prothero, 1992);
(5); a large septal branch from the left coronary artery without a
proper circumflex branch (still controversial); and (6) the blood
support of internal mammary arteries to supply atria, flowing via
cardiomediastinal arteries (Michael et al., 1995; Lutgens et al.,
1999). Finally, it is important to consider that murine strains
and mutations can alter additionally the structure, anatomy,
pathology, and physiology of cells, in an unpredictable way and
that may change with time (Chien, 1996; James et al., 1998; Kass
et al., 1998).
Rat and mouse models show similar advantages, however
rats are the classical choice for studying new drug targets in
cardiovascular research. The larger physical dimension in rats
allows an easier learning of surgical procedures and invasive
hemodynamic assessments. The cardiac blood supply originates
from both the coronary and extracoronary arteries (internal
mammary and subclavian arteries), but the principal limitations
are focused in myocardial function: a short action potential
which normally lacks a plateau phase, and α-myosin heavy-
chain isoform predominates with β-myosin isoform shift under
hemodynamic load or hormonal condition (Swynghedauw, 1986;
Hasenfuss, 1998; Bers, 2001).
Larger species as rabbits and dogs show a higher similarity
with human heart and allow the study of the left ventricular
function in models of heart failure. Like humans, in these two
species, β-myosin heavy-chain predominates and excitation–
contraction coupling processes seem to be analogous to those
in the human myocardium (Lompre et al., 1981; Hasenfuss,
1998). However, canine heart presents a dense collateral coronary
branching with a higher proportional relation of its size with
respect of thoracic cavity. Besides, the proportion of heart to
bodyweight is near the double of the human (Verdouw et al.,
1998).
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Large Animal Models
Direct translation from rodents to humans has to be taken
with caution because of the species-related differences,
such as contractility, architecture, heart rates (HRs), oxygen
consumption, protein expression, etc. . . (Zaragoza et al.,
2011). Instead, large animal models have a better translational
bridge between preclinical and clinical studies because of their
anatomical and physiological similarities (Fernández-Jiménez
et al., 2015a). Predominately, swine species are the election
in preclinical cardiovascular research. Their anatomical heart
features resemble those described in humans: coronary arteries
support a blood flow with a right-side dominant circulation
to the conduction system from the posterior septal artery, and
less subepicardical anastomosis than in other species such as
the dog; the electrophysiological system is more neurogenic
than myogenic with prominent Purkinje fibers; the aorta
has a true vasa vasorum network like that of humans; and
hemodynamic values that allow the extrapolation and translation
of reliable experimental data (Verdouw et al., 1998; Unger, 2001;
Laber et al., 2002; Swindle, 2007; Lelovas et al., 2014). On the
contrary, pigs show a left azygous (hemiazygous) vein which
drains the intercostal vessels into the coronary sinus instead of
precava, and the endocardium and epicardium are activated
simultaneously because of differences in distribution of the
specialized conduction system in the ventricles (Swindle, 2007;
Lelovas et al., 2014). The principal drawbacks of experimentation
with pigs are the high cost of housing and care, especially in
heart failure models. Also changes that occur during animal
growth are particularly important for translational imaging
research, specially the change in the proportional heart weight
to bodyweight ratio. That ratio for a 25Kg-farm pig is 5 gr/Kg
(as human) and this proportion is kept in juvenile animals,
and decreases significantly when the pig reaches the sexual
maturity (Verdouw et al., 1998; Lelovas et al., 2014). Nowadays,
the advent of miniature species like Yucatan, Hanford, Sinclair,
and Göttingen minipigs has significantly solved both limitations
(Bode et al., 2010).
Other species, like the sheep show morphologic similarities
with humans in regard to adult heart size, venous drainage and
physiological responses during the induction of cardiovascular
diseases; thus, sheep allows an experimental scenario highly
used and reliable in biomedical imaging studies. Among the
differences with human anatomy, a left-dominance coronary
artery support (but with a lack of preformed collateral
circulation), the absence of intervalvar septum, the valvular “os
cordis,” aortic valves fragility and the left thoracic drainage of the
azygous vein directly to coronary sinus, are the most noticeable.
Nevertheless, the main limitations of ovine models are the risk
of zoonotic diseases and their condition of ruminant, whose
features of the stomach could interfere in some non-invasive
image acquisitions (Walmsley, 1978; Dixon and Spinale, 2009;
Hill and Iaizzo, 2009).
Methodological Considerations
The ideal scenario for any imaging acquisition conducted in
cardiovascular disease animal models is the one performed
with awake and cooperative animals. However, this requires
acclimatization to restraint to reduce distress as confounding
variable. Conversely, each model under normal sleep conditions
is preconditioned by the type and doses of anesthesia and, in
lesser extent, analgesia used in the experiments. The correct
selection of the anesthetic protocol will determine the reliability
and interpretation of the measured data. All the anesthetics
induce a direct or indirect depression of hemodynamic values
and cardiac functionality. Injectable drugs can create an adequate
level of unconsciousness to perform the injury required in
the model and permit a complete imaging study. But, the
hemodynamic response to the same drugs is different between
species which depends on their metabolic features. This can
hinder an stable imaging acquisition. For example, rodents
generally require 3–5 times the doses used for large animals.
This is critical in those surgical models that imply an open-
chest approach, which means a great impact in the animal
thermoregulation and the size of the infarct area, anesthesia
timing, cardiovascular depression, etc. . . Due to their minimal
systemic metabolism and a short recovery phase, inhaled
anesthetics offer more security for the development of the
procedures; nevertheless, inhalation agents like sevofluorane or
isofluorane protect the myocardium against the insult of the
hypoxic states and diminish significantly the immune cellular
transmigration on inflammatory injuries (Rao et al., 2008; Ge
et al., 2010; Chappell et al., 2011).
During the imaging studies, anesthesia is crucial to maintain
the animal within stable, well-defined physiologic parameters
which is indispensable for detecting critical pathophysiologic
responses associated to the cardiovascular disease model. Not
only the primary affection that is provoked in the animal model
but also variables related with the animal homeostasis in response
to such affection should be taken into account. Also other
indirect factors as risk of hypothermia (and the autonomic
response to it) during surgical procedures can affect the results
of cardiovascular imaging studies. Anesthesia affects the blood
flow, blood oxygenation levels, and cardiac and respiratory
functions, which should be correctly monitored, especially in
those modalities involving long acquisition times. Inhaled agents
are eliminated quicker via the lungs, whereas injectable agents
need to be metabolized by the liver and excreted by the kidneys.
Both sevofluorane and isoflurane are minimally metabolized
by the liver and increase the efficiency of organ perfusion.
This means a less toxic effect to the animal metabolism, rapid
induction, minor impact on cardiovascular function and quick
recovery, which make them in many cases the choice for imaging
studies. Indeed, isofluorane has been described as the election for
PET studies in experimental cardiology just for the improvement
of cardiac radiotracer uptake vs. injectable anesthetics (Gargiulo
et al., 2012a; Lee et al., 2012).
Another key point is the selection of a determined animal
gender. It is has been described that males tend to develop an
eccentric hypertrophy and left ventricular dilatation in certain
cardiovascular disease, whilst females show a more concentric
hypertrophy with a better preserved left ventricular function
(Mahmoodzadeh et al., 2012). Several studies with rodents define
a protective role of the female hormone 17-β-estradiol and
its respective estrogen receptors mediating the cardiovascular
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responses to different pathophysiological situation. This steroid
regulates the expression of a variety of dependent genes related
to myocyte cytoskeletal proteins, cell-to-cell interaction, Ca2+
channels and apoptosis inhibition (Patten et al., 2004; Groten
et al., 2005; Mahmoodzadeh et al., 2010, 2012). For that reason,
females tended more easily to develop a ventricular hypertrophic
response against extreme effort stimuli to preserve the heart
outflow, and showed significantly smaller infarct area after
ischemic myocardial conditions or even maintained the heart
morphology and functionality under pressure overload stimuli
(Wang et al., 2005; Johnson et al., 2006; Babiker et al., 2007;
Patten et al., 2008; Foryst-Ludwig et al., 2011; Mahmoodzadeh
et al., 2012).
Imaging in Myocardial Infarction and
Coronary Artery Disease
Myocardial infarction (MI) may be the first manifestation of
coronary artery disease (CAD) that is the number one cause
of death among adults (Lloyd-Jones et al., 2010; Nichols et al.,
2014). Myocardial tissue-specific biomarkers and high sensitive
imaging techniques allow MI definition as any amount of
myocardial injury or necrosis in the setting of myocardial
ischemia (Thygesen et al., 2012). Animal models on MI are
essential for the better understanding of CAD, for discovering
risk biomarkers of MI, for studying early diagnostic test, and also
for establishing beneficial effects of new therapies.
Small and Large Animal Models for MI
Assessment: Mouse and Porcine Models
In small animals, including mice and rats, the left coronary
artery ligation procedure developed by Pfeffer et al. (1979) is
the most common method used to induce acute myocardial
damage. The artery might be either permanently or temporary
occluded to reproduce human ischemia/reperfusion injury. In
respect to large animals, swine is the preferred animal model
of heart damage, because of the absence of collateral coronary
circulation, similar arterial anatomy compared to humans and
the suitability to have clinically relevant imaging techniques to
accurately quantify area at risk or infarcted tissue (Crick et al.,
1998). One of the most widely used model of MI in pigs is
the angioplasty balloon occlusion of the left anterior descending
coronary artery (Ibanez et al., 2007). Moreover, the development
of gene-engineered animals with the advent of molecular genetic
techniques during the last years has allowed an explosion in the
number of models resulting in a tremendous progress in the
understanding of myocardial diseases.
Different Non-invasive Imaging Modalities to
Assess Myocardial Structure and Function,
Inflammation, and Viability in Animal Models
of MI
Myocardial Structure and Function: Techniques and
Current Evidence
Two-dimensional echocardiography is a well-established tool
that has have been largely used for the assessment of cardiac
function and structure using techniques and indices familiar
from human echocardiography. It offers a rapid and low
cost evaluation of heart anatomy, function and biomechanics
(Richardson et al., 2013) and response to treatment (Bao et al.,
2013; Matthews et al., 2013). But, its results depend on the
body complexion, echographic window and the HR of the
scanned animal. As a result, ultrasound based methods have
been mostly limited to small-animal models these days. The
advent of higher frame rates and smaller probes operating at
higher frequencies equipment’s have facilitated imaging of mice,
a setting where CMR is still challenging. Basic measurements
of LV systolic function, LV mass, and LV chamber dimensions
are easy to achieve from a parasternal long and short-axis view
of the heart. In the absence of wall motion abnormalities, M-
mode is an accurate method for evaluating LV structure and
function using the Teichholz method for fractional shortening
(FS%) and ejection fraction (EF%) estimation (Tanaka et al.,
1996). However, inmicemodels ofMI, wall motion abnormalities
and systolic function should be determined in 2D mode
echocardiography with consecutive parasternal short-axis planes
using the Simpson’s rule (Gao et al., 2000). It is important
to note that marked changes in echographic measurements
occur when mice are anesthetized (Rottman et al., 2003).
Anesthesia depresses HR, and the FS% is directly affected
by cardiac frequency. Thus, it is important when protocols
required consecutive measurements to perform all echoes under
the same conditions. Regarding diastolic dysfunction, it is a
critical condition where blood filling of the LV is impaired. It
accompanies, and sometimes precedes many disease conditions
like ischemic heart disease, but it is more difficult to define and
to measure than systolic dysfunction. Moreover, its echographic
measurement are highly affected by loading conditions, age and
HR. Transmitral filling, alterations in the A-wave or the E/A ratio
haven been used to define diastolic abnormalities. However, E
and A waves are fused due to rapid HR in mice, so as, other
indices like color M-mode flow propagation velocity (Schmidt
et al., 2002), isovolumentric relaxation time, the A’-wave or the
E’/A’ ratio using tissular Doppler imaging (Schaefer et al., 2003,
2005), also the Tei index (Tei et al., 1995) that characterize
global, systolic and diastolic left ventricular function after MI,
have been used in mice. However, the accuracy with which
these measurements quantify diastolic dysfunction is still open
to discussion (Scherrer-Crosbie and Thibault, 2008).
Cardiac Magnetic Resonance (CMR) is up to date the
preferred technique for the assessment of cardiac morphology
and function in animal models (Stuckey et al., 2008; Makowski
et al., 2010). CMR provides non-invasive high image quality
tomographic views of the heart with sub-millimeter anatomical
detail, high tissue contrast and excellent reproducibility, which
can be used for accurate functional and structural assessment in
coronary heart disease (Sinitsyn, 2001). They have been used to
serially evaluate left and right ventricular dysfunction.
Medium-large animal models can be studied with
conventional procedures established in the clinic for patients,
but imaging small animal models with CMR is challenging due
to their faster HR and smaller dimensions of the heart, and
requires the use of high-field (>4.7T) scanners or substantial
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modifications of conventional protocols used in clinical 1.5
or 3T platforms (Gilson and Kraitchman, 2007; Bunck et al.,
2009). Cine sequences in Magnetic Resonance Imaging (MRI)
are used to study all relevant functional parameters of the left
ventricle (LV) such as EF, ventricular volume, cardiac mass, and
cardiac output with high accuracy (Franco et al., 1999). Several
ECG-gated spin-echo and multiphase gradient-echo (cine MRI)
have been developed for quantifying LV parameters in mice with
similar reliability (Ruff et al., 1998; Slawson et al., 1998) becoming
the gold standard for LV assessment in rodents (Slawson et al.,
1998; Franco et al., 1999). Also, high in-plane resolution (0.1
× 0.1mm) cine MRI has been developed to quantify right
ventricular function in murine models (Wiesmann et al., 2002).
Other techniques for quantitative wall-motion imaging like
myocardial tagging (Epstein et al., 2002; Zhou et al., 2003) or
velocity-encode phase-contrast imaging (Espe et al., 2015) have
been optimized for animal studies. These approaches permit the
tracking of regional myocardium and enable the quantification
of principal strains and directions (radial, circumferential, and
longitudinal) to depict the extent of the changes in contractility
after MI (Young et al., 2006).
Myocardial ischemia also leads to a variety of changes in tissue
structure. Myocardial fibrosis is the main structural damage
after ischemia/reperfusion injury. Scar tissue can be evaluated
with inversion recovery echo-pulse sequences for late gadolinium
enhancement to differentiate between reversible damage and
infarcted myocardium after MI (Figure 1; Kim et al., 1999). Also,
diffuse microfibrosis can be detected in the myocardium using
recent T1-mapping sequences in animals (Stuckey et al., 2014;
García-Álvarez et al., 2015). Nevertheless, efforts are still required
to further improve and standardize protocols and to generate
reference values for each animal model on cardiovascular disease.
Myocardial Inflammation: Area at Risk: Techniques
and Current Evidence
The area at risk (AAR), defined as the hypoperfused myocardium
during an acute coronary occlusion, is a major determinant of
infarct size and clinical outcomes in MI. Additionally, accurate
AAR quantification is important because it has been used as an
end-point in clinical trials testing the efficacy of cardioprotective
FIGURE 1 | Cardiac magnetic resonance images of an anterior acute
myocardial infarction in a pig model of ischemia/reperfusion injury. (A)
Area at risk in T2-STIR sequence and hyperintense zone in anterior septum.
(B) Necrotic zone in late enhancement sequence at the same zone. Published
with publisher’s permission. Original source: Fernández-Friera et al. (2013).
Copyright © 2012 Sociedad Española de Cardiología. Publicado por Elsevier
España, S.L. All rights reserved.
interventions (Feiring et al., 1987). Single-photon emission
computed tomography (SPECT) is the traditional reference
method for determining AAR by injection of technetium-based
tracer before opening of the occluded vessel. However, CMR has
been proposed as an alternative approach over the last years
because of higher spatial resolution and the absence of tracer
administration need or radiation exposure (Carlsson et al., 2009).
In particular, T2-weighted (T2W) edema-sensitive sequences
have enabled the identification of acutely ischemic myocardium
by detecting increased signal intensity that reflects myocardial
water content (Aletras et al., 2006; Friedrich et al., 2008).
T2W imaging, however, is often limited by motion artifacts,
incomplete blood suppression, low signal-to-noise ratio and coil
sensitivity related-issues of surface coil. Newer quantitative CMR
methods include: (1) T1 and T2 mapping imaging (Figure 2)
that allow direct measurement of intrinsic tissue properties.
These sequences are less dependent on confounders affecting
signal intensity (Ugander et al., 2012) and their accuracy for
AAR quantification is high compared to microsphere blood
flow analysis in a dog model of ischemia/reperfusion injury
(Fernandez-Jimenez et al., 2015b); (2) BOLD or modified blood
oxygen level-dependent sequences which have been recently
proposed to detect ischemic myocardium in a dog model of
severe coronary stenosis (Tsaftaris et al., 2013); (3) Targeted
microparticles of iron oxide, which shorten T2 and T2* relaxation
times. By tracking up-regulated vascular cell and intercellular
adhesion molecules, such as VCAM and ICAM, it is possible
to detect and localize myocardial ischemia (Grieve et al., 2013);
(4) Balanced steady-state free precession sequences with T2
preparation have also been proposed to detect myocardial edema
in a porcine model and in patients with reperfused acute MI
(Kellman et al., 2007).
In addition to CMR approaches, pre-reperfusion
multidetector Computed Tomography (CT) imaging has
also been described as a method to assess AAR size in a porcine
acute MI model (Mewton et al., 2011).
Myocardial Perfusion and Viability by PET
and MRI
Positron Emission Tomography (PET) currently plays an
important role in clinical cardiology (Bengel et al., 2009). The
basic principle of PET is the coincidence detection of the
annihilation photons emitted after the emission of a positron
by a beta+ radioisotope. The spatial resolution of PET images
is currently in the range of 4–7mm for clinical scanners
and about 1mm for small animal systems. Higher detection
sensitivity allows measuring radiotracer at nano- to pico-molar
concentrations. In addition, PET is a truly quantitative imaging
tool that measures absolute concentrations of radioactivity in the
body and allows for kinetic modeling of physiologic parameters
such as absolute myocardial blood flow or glucose use. The data
acquisition can be synchronized with an ECG or respiration
signal and retrospectively used to obtain gated images. PET
systems are nowadays combined with CT systems that offer fused
anatomical and functional images. Combined PET and MRI
systems have recently appeared as and attractive option but their
use is still mostly limited to research studies (Nekolla et al., 2009).
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FIGURE 2 | Examples of T2 (A) and T1 parametric maps in animal models of myocardial infarction. (A) Shows the dynamic changes in T2 relaxation times in
the ischemic region after permanent coronary occlusion and reperfusion in a pig. (B) Shows pre contrast (upper row) and post-gadolinium contrast on a mouse
model. Adapted from Figure 5 of Fernández-Jiménez et al. (2015a) and from Figure 2 of Coolen et al. (2011) with original publisher’s permission (Bio Med Central).
Cardiac imaging in small animals is challenging due to the
small ventricle volume and wall thickness and the high HR
(Gargiulo et al., 2012b). Dedicated small animal PET systems
with high spatial resolution and increased sensitivity have
been developed (Levin and Zaidi, 2007). In the other hand,
large animal models are typically imaged in clinical systems
(Teramoto et al., 2011). In planning longitudinal PET studies
with animals, many variables interfering with the accuracy of the
experimental results must be taken into account (Adams et al.,
2010; stress related to physical restraint, fasting, warming and
anesthesia).
Myocardial Perfusion
Myocardial MRI based techniques are based (in large animal
models and in humans) on regional differences in myocardial
signal intensity during the first passage of an intravenously
administered dual-bolus of gadolinium-based contrast agent,
although quantitative approaches systemically underestimate
myocardial reserve and require many manipulations and have
limited inclusion in the clinical routine. For the successful
application of these methods in mice, imaging technology
requires the complete acquisition of imaging dataset at every
single or every second heartbeat using non-conventional MRI
pulse sequences. MRI offers the advantage by comparison
with nuclear medicine-based techniques of high resolution
and consequently betters assessment of transmural perfusion.
MRI perfusion technology has also the advantage that can be
integrated in routine CMR protocols of functional assessment
and late gadolinium enhancement. Most of the semi-quantitative
methods are based on the contrast enhancement ratios or upslope
indexes, although these systematically underestimate myocardial
perfusion. Finally, recent alternatives for absolute quantification
included dual saturation strategies of single bolus acquisition,
that will make easier to implement in clinical protocols (Sánchez-
González et al., 2015).
Alternatively, other MRI based—Arterial Spin Labeling (ASL)
perfusion methods does not use an exogenous contrast agent
and has been used for single slices to measure and quantify
myocardial perfusion also in small animals, although with long
acquisition times (Kober et al., 2005). ASL uses the water of the
blood as endogenous tracer and allows in vivo quantification
of the absolute perfusion and the regional blood volume in
the myocardium. These methods showed good agreement with
standard ex vivomicrospheres technique and is sensitive enough
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to detect and visualize regional alterations of the perfusion after
MI (Streif et al., 2005).
Basic experiments based in nuclear medicine have provided
complement or additional information to MRI based methods.
Myocardial perfusion imaging with PET is a standard tool for
detection of CAD, risk stratification of patients, and guidance
of therapeutic interventions (Di Carli et al., 2007). Regional
blood flow at rest may be normal until the stenosis is higher
than 90%. However, autoregulation is incapable of preserving
maximum blood flow during exercise or pharmacological stress
test leading to reduced myocardial blood flow relative to demand
and stress-induced ischemia. Thus, in a patient with coronary
artery stenosis, when acute myocardial ischemia occurs, the
initial abnormality is an imbalance in blood flow between the
hypoperfused and normally perfused areas (Di Carli et al., 2007).
CT coronary angiography is considered the gold standard for
evaluating the presence and the severity of coronary stenosis,
which provides the anatomical extent of disease. However,
perfusion imaging provides hemodynamic significance of
epicardial stenosis. PETmyocardial perfusion imaging combined
with tracer-kinetic modeling can provide absolute quantification
of regional myocardial blood flow of the LV. Tracer kinetic
modeling requires dynamic imaging beginning briefly before the
tracer injection and monitoring of tracer distribution in the
myocardium for 2–30min depending on the tracer and model.
Rest and stress scans are typically performed sequentially and
stress scans in animals are achieved by pharmacological stress by
infusion of adenosine, dipyridamole, or dobutamine.
The available flow agents are characterized by a rapid
myocardial extraction and by a cardiac uptake proportional to
blood flow. PET radiotracers used for evaluation of myocardial
blood flow include 13NH3(see Figure 3), 82Rb, and H152 O.
However, their short half-life limits their widespread clinical
use, because of the need for nearby cyclotron (13N and 15O)
or generator (82Rb). Other agents based on 18F as Flurpiridaz
(Packard et al., 2014) shows potential to spread the use of PET
for cardiac perfusion imaging, evenwith animalmodels, as it does
not depend on onsite cyclotron or generator.
Myocardial Metabolic and Energetic Viability
Alterations in myocardial substrate metabolism are critical in the
pathogenesis of many cardiovascular diseases. MI is associated
with numerous biochemical and functional changes in the
necrotic tissue, in the AAR, and in the remote myocardium.
18F-fluorodeoxyglucose (FDG) is a glucose analog that is widely
available due to its success as a metabolic imaging tracer
in clinical oncology. FDG traces myocytic glucose uptake
and can be used to quantify regional myocardial glucose
metabolism (Dilsizian et al., 2009; see Figure 3). FDG is
employed to determine the extent of myocardial viability or
potentially reversible contractile dysfunction in response to
revascularization as well as the extent of scar tissue or irreversible
contractile dysfunction. Increased FDG uptake can be observed
in ischemic tissue while significantly reduced or absent uptake
indicates scar formation.
The diagnostic quality of the myocardial FDG image depends
on the concentration of tracer in both myocardium and blood.
Myocardial FDG uptake depends quantitatively on plasma
concentrations of glucose and insulin, the rate of glucose
utilization and the relationship between FDG and glucose defined
by the lumped constant. High plasma concentrations of glucose
lower the fractional utilization of FDG and thus degrade the
quality of myocardial FDG uptake images. Myocardial glucose
uptake also depends on myocardial work, plasma levels of free
fatty acids, insulin, catecholamines, and oxygen supply. FDG
uptake is heterogeneous in normal myocardium in the fasting
state. Therefore, attempts have been made to standardize the
metabolic environment for human myocardial FDG imaging
(Knuuti et al., 1992), whereas procedures for animal imaging
vary widely (Gargiulo et al., 2012b). In humans, patients are
studied under fasting conditions following oral glucose loading
or during hyper-insulinaemic-euglycaemic clamping to improve
image quality and diagnostic accuracy.
Alternatively, Magnetic Resonance spectroscopy (MRS),
primarily based in 31P and 1H provides an energetic profile
(ATP, PCr, etc. . . ) or lipid content, respectively that in are
both connected to the possible change in myocardial substrate
utilization from fatty acid toward glucose in the context
of myocardial ischemia/reperfusion injury or provides useful
insights into the effects of obesity on the heart. These methods
have sometimes used to evaluate the improved cardiac energetic
and function effect of novel drugs (Bao et al., 2011). 31P MRI
is the only method available to provide non-invasive measures
of endogenous quantitative concentration of these energetic
metabolites and creatine kinase kinetics (Bottomley et al., 2009).
Additionally, 13C in natural isotopic abundance is per se not
very informative. However, possible hyperpolarization with an
SNR increase in five orders of magnitude is the technique with
FIGURE 3 | Representative midventricular short-axis slices PET myocardial perfusion at rest and PET myocardial metabolism using 13NH3and 18FDG
tracers respectively in pigs studied in the chronic (A) and acute (B) phases after myocardial infarction. From Lautamäki et al. (2009) Figure 1. With
permission.
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promising future for enhanced 13C MRS studies, particularly of
the glycolytic metabolism of the heart. There are some reports
of 13C metabolic images of lactate, alanine, bicarbonate and
pyruvate in a pig heart following coronary occlusion (Bottomley
et al., 2009).
Heart Failure
A variety of animal models have been used to mimic the human
disease with the highest interest in medical cardiology (Table 1;
Verdouw et al., 1998; Dixon and Spinale, 2009; Patten and Hall-
Porter, 2009; Abarbanell et al., 2010; Houser et al., 2012). HF
is caused by an unable heart to maintain oxygen level that
vital organs demand deriving from an impaired blood filling
and/or ejection (Houser et al., 2012). According to these two
different causes, there are two phenotypes of HF, ones derived
from the systolic dysfunction, where the EF decreases below 50%,
called HF with reduced EF; and ones derived from a diastolic
dysfunction, where the EF remains above 50%, called HF with
preserved ejection EF. Valve diseases, hypertension, myocardial
ischemia and genetic abnormalities that caused dilated and
restrictive cardiomyopathies are the most common mechanisms
used for creating experimental HF. Characterization of animal
models of HF requires revealing an insufficient cardiac output,
on one hand the left-, right-, or biventricular cardiac dysfunction,
and o pulmonary findings compatibles with the course of HF
(Houser et al., 2012).
Cardiac Hypertrophy
Several strategies have been described to induce an adaptive
response to pressure overload, sarcomeric mutations or
pulmonary/artery hypertension, to mimic the hypertrophic
transformation of the heart: (1) hypertrophic growth where
load exceeds heart output, (2) study of compensatory events to
normalize workload/mass ratio and cardiac output, and (3) HF
because of ventricular dilatation (Meerson, 1961). Aortic and
pulmonary artery stenosis are the most common methods for
stressing the heart for a pressure overload (Tarnavski et al., 2004).
The critical feature is to establish a normalized constriction of
the artery to observe the increased difference between the left
ventricular and aortic pressures or the difference between right
ventricle (RV) and pulmonary artery. In non-rodent models, the
normalization of the injury is fairly easy due to the feasibility
of previous imaging studies. The measurement of the artery
determines the precise restriction desired. A recent publication
of RV failure in rabbits details the constriction induction of the
pulmonary artery by the inflation of a 5-mm surgically implanted
band controlled by the echocardiographic measurement of the
right ventricular end-systolic pressure (McKellar et al., 2015).
Imaging technologies are used for hypertrophic progress
evaluation for the development of new therapies. However, the
main disadvantage of these models is the period required to
observe each stage of the cardiomyopathy, involving 2–3months.
On the other hand, the rodent models display an abrupt and
acute hemodynamic instability. Heart morphological alterations
are quickly acquired with a certain grade of variability depending
of proportional reduction of the arterial lumen (−70%). The
interest of the murine models is focused on the study of the
compensatory events that occur after hypertrophic growth.
Other models that induce pressure overload without a
required surgical expertise are: pulmonary hypertension (PH)
by beads inoculation, genetic models of arterial hypertension
and arrhythmogenic right ventricular cardiomyopathy. Murine
genetic models and arrhythmogenic pathologies show a great
advantage against other species. The spontaneous hypertension
of rat (SH strains) or those induced in mutant mice are well
characterized. However, the arrhythmogenic right ventricular
cardiomyopathy of the Boxer andHypertrophic Cardiomyopathy
of MainCoon//Persian cats remain the best animal models
for the study of both diseases regarding their similarities in
genetic mutations etiologies and analogous mechanical-electrical
dysfunctions (Kittleson et al., 1999; Basso et al., 2004; Palermo
et al., 2011).
Dilated Cardiomyopathy
Animal models of dilated cardiomyopathy (DCM) should exhibit
the structural and mechanical alterations observed in humans:
LV dilatation, eccentric hypertrophy, wall thinning, reproducing
cellular/molecular/neurohormonal features, depressed chamber
output/flow, reduced ventricle contractility, and lusitropy,
elevated filling pressure, and intolerance to stress situation
due to a low functional reserve. Several strategies have been
implemented (from rodent to large animal) to develop this
disease phenotype.
The most used model is the myocardial ischemic injury,
which can be performed with a permanent, temporary or
progressive occlusion of the left coronary, just trying to mimic
the atherosclerotic CAD. Depending on the animal species
and surgical expertise, the technique can be performed in
a closed or open-chest approach applying a surgical suture,
beads microembolization, an intracoronary balloon-occlusion,
or ameroid constriction. However, these experimental lesions
are concentric contrary to the eccentric occlusion in human
atherosclerosis (Bianco et al., 2009). Other strategies for
the induction of congestive HF are: toxicological effect of
doxorubicin or isoproterenol, pacing-induced tachycardia or
genetic factors. In most of DCM animal models it is possible
to observe a significant remodeling without severe clinical
signs (Mann and Bristow, 2005). Asymptomatic LV dysfunction,
reduced blood flow, elevated cardiac filling pressure, or other
changes in hemodynamic could be absent while myocyte
hypertrophy and fibrosis might be observed histologically. This
is quite important to decide the experimental timing and the
correlation with symptoms (Houser et al., 2012).
Imaging in Animals Models of HF
Current non-invasive imaging techniques developed in research
allows longitudinal evaluation of HF. Echocardiography remains
as the gold standard for assessment of cardiovascular structure
and function in rodents (Ram et al., 2011). However, CMR
and PET-CT have gained importance in small animal research
for further cardiac evaluation in the context of heart disease,
especially evaluating anatomy and metabolism. In particular
CMR is becoming an useful tool in both, systolic and diastolic
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TABLE 1 | Schematic comparison of the different animal models used in cardiovascular imaging research.
Specie Model Failure etiology Advantages Disadvantages
CARDIAC HYPERTROPHY





Easy use of GEM animals. Hypertrophy
developed rapidly (2–3 weeks)
Surgical skills. Acute hypertension and
expense of equipment for cardiovascular
imaging and physiology assessment
Mouse Isoproterenol infusion Toxic injury of
myocardium
Minimal surgery and good scenario for
pharmacological or gene therapy







The onset of hypertension is gradual, being the
heart failure in later stages. Genetic origin of
hypertension. No surgery
Long experimental period (6–12 months)
Rat Ascending aortic and
pulmonary artery
constriction
Gradual to quick onset
pressure overload
Gradual to quick onset hypertension Less GEM animals and similar cost of
equipment for cardiovascular physiology
assessment than mouse
Rat Arteriovenous shunts Overload of ventricular
chambers
Progressive heart hypertrophy, more rapidly in
the right ventricle. Well tolerate and it possible
to reverse the volume-overload state
Greater surgical skills, with a grade of
hypertrophy fistula localization-dependent




Human mimicking alteration of sarcolemma
calcium handling
Special and expensive requirements for
husbandry




Imaging technology allows normalizing the





Myocyte function and structure modification High risk of mortality dose dependent
Dog Aortovenus shunt Volume overload Progressive heart hypertrophy, more rapidly in
the right ventricle
Not so well tolerated than rats. Frequent



















Progressive hypertrophy and animal well
adapted (constriction grade progresses with
animal growth)






Progressive hypertrophy of right ventricle and















Progressive hypertrophy of right ventricle and
final heart failure by dilated cardiomyopathy. No





Dilated cardiomyopathy Genetic modifications of structural and
functionality of cardiomyocytes. No required
surgery
Clinical reliability restricted to the molecule of
study: e.g., TNF-α overexpression
(Continued)
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TABLE 1 | Continued
Specie Model Failure etiology Advantages Disadvantages
Rat Isoproterenol toxicity Toxicological
aggression
Severe structural modification by necrosis and
fibrosis of myocardium
Less GEM animals and similar cost of
equipment for cardiovascular physiology
assessment than mouse
Rabbit Pacing Tachycardia Congestive failure by
low output
Mimic myocardial alteration of human
edematous chronic low output
Limited imaging technology due to paced heart
rate (400 beats/min)
Rabbit Balloon occlusion of
circumflex branch of
left coronary artery
Myocardial infarction Artery occlusion by catheterization Great skill and specific material
Dog Pacing Tachycardia Congestive failure by
low output
Mimic myocardial remodeling, neurohumoral








No surgery requirements Microspheres are chemically inert. Extensive
arterial pattern of heart. Time consuming
Pig Pacing Tachycardia Congestive failure by
low output
Mimic myocardial remodeling, neurohumoral
activation and subcellular dysfunction












Mimic human disease condition Surgical technical experience and skill. There is
a myocardial recovery in chronic studies
Sheep Pacing Tachycardia Congestive failure by
low output
Mimic myocardial remodeling, neurohumoral
activation and subcellular dysfunction







No surgery requirements and resemble human
condition than dog
Zoonotic risk. Microspheres are chemically
inert. Extensive arterial pattern of heart. Time
consuming
MYOCARDIAL INFARCTION
Mouse Left coronary ligation
(total occlusion or
ischemia/reperfusion)
Myocardial infarction Easy use of GEM animals, low cost of
husbandry and feasible cardiovascular
assessment. Suitability for follow-up and
survival studies.
Great surgical skill and expensive technological
requirements. Limited sample collection (animal
size)
Rat Left coronary ligation
(total occlusion or
ischemia/reperfusion)
Myocardial infarction Surgical procedure easier than in mouse and
more volume of samples. Lower cost than large
animals. Suitability for follow-up and survival
studies.
Less GEM animals and similar cost of
equipment for cardiovascular physiology
assessment than mouse
Rabbit Left coronary ligation
(total occlusion or
ischemia/reperfusion)
Myocardial infarction Surgical procedure easier than in rodents and
more volume of samples Lower cost than large
animals.
Thoracotomy surgery required
Dog Left coronary ligation
(total occlusion or
ischemia/reperfusion)
Myocardial infarction Surgical procedure easier than in rodents and
more volume of samples Lower cost than large
animals.
High death incidence by arrhythmias
Pig Angioplasty balloon
occlusion of the left
anterior descending
coronary
Myocardial infarction Anatomy and pathology closed to human.
Good suitability to undergo imaging
techniques. No surgery requirements.
Require skills for coronary catheterization and
surgical specific material
Zebrafish Myocardial criolesion Myocardial infarction Heart remodeling and regenerative model Far of mammals biology
(Continued)
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TABLE 1 | Continued








Easy use of GEM animals, low cost of
husbandry and feasible cardiovascular
assessment. Great valuable data of molecular
and cellular events.
Not mimic exactly the human chronic disease.






arch and thoracic aorta
lesions
Easy husbandry and feasible artery imaging
acquisition.
Great skill for vessel damage, long term
experimental induction of atherogenic lesions
and no coronary affection
Rabbit Watanabe WHHL (LDL
Receptor deficiency)
Atherosclerosis, Aortic
arch and thoracic aorta
lesions
Easy husbandry and feasible artery imaging
acquisition. Possible finding of coronary artery
lesions. Not necessary high fat diet.
Unstable atherogenic plaque which could







Model closed to human disease Long term experimental induction of
atherogenic lesions. Skills for catheterism
PULMONARY HYPERTENSION
Rat Chronic Hypoxia Increase in vascular
tone
Repeatable maintained increase in pulmonary
artery and RV pressure accompanied by RV
remodeling
Minimal vascular remodeling. Suitable just for
small animals





Equal than chronic hypoxia more
angiobliterative changes. More increase in RV
pressure and more RV hypertrophy
Suitable just for small animals
Rat, dog,
pig, sheep
Monocrotaline Endothelial damage Produces RV failure and vascular remodeling No plexogenic arteriopathy
Dogs pig,
sheep
Beads or clots injection Decrease in total vessel
area
Acute increase in pulmonary pressure RV
remodeling
Decrease of the severity of vascular and RV
changes with time. Hard to titrate the dose.
High mortality in some reports
Pig, Rat Aortocaval shunt Increase in pulmonary
artery flow





Vascular banding Decrease in vascular
compliance
Controllable and maintained increase in
pulmonary artery pressure. RV remodeling
Requires surgical skills. Complications related
with surgery
HF studies in murine models (Loganathan et al., 2006; Chung
et al., 2013; Constantinides, 2013). Literature on advance imaging
protocols and cardiac echocardiography and MRI mouse models
of HF is very extensive, therefore only those aspects helpful in the
assessment of HF in mice are described.
Impaired systolic function is the main characteristic of HF
with reduced EF animal models. Main cardiac findings are
reduced LV EF, dilated or overload LV and coronary flow
disturbs. Furthermore, assessment of LV regional wall motion
abnormalities and calculation of wall motion score index offers
to investigators an interesting tool to complement systolic
dysfunction characterization and ameasurement of heart damage
extension, especially in ischemic injury.
Models of HF with preserved EF have predominantly LV
diastolic filling alterations. Therefore, in these studies evaluation
of mitral inflow pattern, pulmonary vein flow and left atrium
dimensions could be essential for evaluating this condition. An
important consideration to mention is that diastolic impairment
does not noticeable affect cardiac output, so atrial diameter
enlargement and pulmonary changes related to congestion could
be useful to determine the develop of HF.
Mice Transthoracic Echocardiography
Two-dimensional (2D), motion-mode (M-mode) and color and
pulse wave Doppler (CD and PW, respectively) are the basic
techniques used in research (Ram et al., 2011; Chen et al., 2012;
Moran et al., 2013). Parasternal long axis view (PLAX) and
parasternal short axis views (PSAX, at basal, medium, and apical)
in 2D and M-mode allows entirely LV visualization, therefore
LV function, regional wall motion as well as chamber and wall
dimensions can be accurately determined (Zhang et al., 2007;
Fayssoil and Tournoux, 2013). Apical four-chamber view is used
to visualize both ventricles and as ultrasounds can be aligned
with blood flow through mitral and PW Doppler is set in this
plane to study mitral inflow pattern. Additional views or PLAX-
angled views have also been described in mice to study coronary,
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pulmonary vein and pulmonary artery flows, which can be useful
in the context of diastolic and systolic dysfunction (Wu et al.,
2012; Cheng et al., 2014).
Conventional echocardiographic measures lack sensitivity for
capturing subtle variations in global ventricular performance
(Bauer et al., 2011). In this regard, novel echocardiographic
techniques based on tracking tissue motion have emerged for
clinical use and animal cardiac research to assess strain. These
may provide quantitatively evaluation of myocardial function
and early detection of ventricular performance alterations.
Doppler tissue imaging (DTI) and speckle-tracking imaging
(STI) based on strain analysis are the main echocardiographic
tools described in human and small animal models in this regard,
although current applications remain limited (Mor-Avi et al.,
2011). In DTI, the same Doppler principles are used to identify
signals of myocardial tissue motion. Peak myocardial velocities
of early and late diastolic and systolic waves can be measured
(also in mice) in the anterior/posterior LV wall for the radial
component, and in the lateral free LV wall for the circumferential
component on the PSAX view (Ho and Solomon, 2006; Mor-
Avi et al., 2011; Ferferieva et al., 2013). STI based of strain
analysis detects the gray scale “speckles” within the tissue on
2D ultrasound imaging and its movement during cardiac cycle
and has been recently used for the estimation of the radial and
circumferential strain in small animal models (Mor-Avi et al.,
2011; Ferferieva et al., 2013).
In mice, assessment of deformation parameters through DTI
or STI based on strain analysis correlated well with invasive
hemodynamic measure of myocardial contractility and both
techniques could be equally acceptable for assessing LV function
(Ferferieva et al., 2013). However, these techniques are not
yet routinely established in the echocardiography protocols of
cardiac disease. The use of DTI and STI based on strain analysis
to provide good cardiovascular phenotype in mice are of great
interest but improvement of the analysis should be develop
to make these new tools robust, reproducible and more user-
friendly (Fayssoil and Tournoux, 2013).
In HF with reduced EF models, typically derived from
systolic alterations, LV EF is the major parameter to determine
this condition and can be determined from both, 2D and M-
mode PLAX views. It is important to mention that in ischemic
injury, M-mode echography cannot accurately estimate LV
EF because the ventricle shape is abnormal, and geometric
models and algorithms assumptions cannot be assumed. In
these cases, EF is better estimated using the area-length formula
in an 2D PLAX view; if additional 2D PSAX has been taken
at basal, medium and apical, Simpson formula to calculate
LV EF and regional wall motion can also be performed. LV
dilatation or overload can be demonstrated obtained the end-
diastolic volume of the LV, usually from 2D PLAX. Evaluation
of coronary flow in murine models of HF with reduced EF
could be essential in some cases as coronary disturbance
could lead to abnormal myocardial perfusion and therefore
could compromise systolic function. Hyperemic peak diastolic
velocity and coronary flow reverse are the principal changes in
coronary flow during ischemic injury and reduced EF (Wu et al.,
2012).
Echocardiography evaluation of HF with preserved EF in
mice, normally derived from diastolic alterations, can be
challenging as small heart size and rapid ventricular rates make
evaluation of diastolic function difficult (Chung et al., 2013).
Variation in the mitral flow is the most consistent finding in
these studies. Mitral inflow pattern can be achieve in the apical
view, and common parameters altered are E wave-A wave ratio,
isovolumetric relaxation time, E wave deceleration time and A
wave time (Wichi et al., 2007; Ram et al., 2011; Fayssoil and
Tournoux, 2013). Pulmonary vein flow changes are commonly
used in human echography and could be a future marker of
diastolic dysfunction in rodents but no consistent changes have
been described. Pulmonary veins in these animals differ from
human as venous confluence with a single orifice enters the left
atrium in mice, thus, altering the pressures and, therefore, the
wave patterns (Yuan et al., 2010).
Left atrial dilatation measured form 2D and M-mode long-
axis has been described as a parameter indicating pulmonary
congestion (Finsen et al., 2005), therefore, it could be used in
both, reduced and preserved EF models, but could be especially
useful in preserved EF where reduced cardiac output cannot
be assessed. Pulmonary artery flow varies depending on lung
abnormalities and mice have similar pattern to that observed
in humans (Thibault et al., 2010). In both, HF with reduced or
preserved EF, if there is a maintained pulmonary congestion,
high pulmonary pressures can be achieved and typical pattern
of hypertension can be visualized. Acceleration and total ejection
time ratio is reduced in accordance with increase in pulmonary
pressure in hypertension murine models (Thibault et al., 2010),
whereas in some models of HF such as ischemic injury, the
changes in arterial flow have not been very consistent with the
presence or absence of pulmonary congestion (Finsen et al.,
2005).
Mice Cardiac MRI
In vivo MRI provides excellent views of cardiac structures
and allows high quality spatial resolution of the heart, and
recently has emerged as an accurately instrument for functional
cardiac evaluation as high temporal resolutions are also achieved
(Yue et al., 2007; Figure 4). Cardiac gating is essential to
reduce the level of motion artifacts and therefore, to obtain
images of sufficient quality (Cassidy et al., 2004). Assessment
of cardiac anatomy, regional wall motion, myocardial perfusion,
myocardial viability plus cardiac chamber quantification, and
cardiac function are applications described in mice (Pohlmann
et al., 2011). Conventional views in mice are similar to those
used in human cardiac MRI. Long-axis, two and four-chamber
views as well as a multi-slice short-axis view from base to apex
are commonly used in bright-blood and black-blood spin-echo.
CMR in HF with reduced EF models is becoming
progressively more used as it allows precisely data of LV volumes
with no need of making geometric assumptions regarding
ventricular shape, which is especially important in ischemic
injury models. In these models, MRI also allows measuring the
total infarcted area as the scar can be well visualized. Besides,
the high anatomical resolution and improvements achieved in
temporal resolution make MRI a powerful tool to assess cardiac
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FIGURE 4 | Representative short axis (upper panel) and long axis (low
panels) cardiac magnetic resonance images taken at the end of
diastole (left panels) and systole (right panels) in WT mice. Adapted
from Figure 3 in Cruz et al. (2015).
systolic dysfunction and wall motion, not only in LV but also
in the RV. Normally, LV and RV EF as well as volumes are
calculated after obtaining planimetry of each short-axis slice in
end-systole and end-diastole.
As it has been describe previously in this report, non-
invasively imaging evaluation of diastolic dysfunction in rodents
is limited because of the short diastolic period. As most of
the HF with preserved EF models are characterized by diffuse
myocardial fibrosis and structural alterations, MRI has become
an important imaging technique to describe cardiac mass, tissue
changes, and interstitial fibrosis through special analysis as
pixel intensity values (Loganathan et al., 2006). Furthermore,
evaluation of LV filling rate calculated from slopes of the volume-
time curves can also provide relaxation information useful for
determining diastolic dysfunction in these models (Yu et al.,
2007). Finally, CMR can be simultaneously used to assess the
progression of ventricular dysfunction with lung congestion.
This non-invasive technology is especially applicable to serial
studies and in drug discovery programs exploring the use of
novel pharmacological or molecular agents for treatment of heart
failure and/or pulmonary congestion (Alsaid et al., 2012).
New Challenge in Heart Failure Imaging
One of the ultimate goals of HF treatment is aimed to cardiac
repair by the regeneration of the myocardium after injury.
The mammalian heart is one of the least regenerative organs
in the body, although postnatal hearts undergo some degree
of cardiomyocyte renewal during normal aging and disease.
Together with mouse, zebrafish has proven to be a particularly
useful model, given its amenability to genetic manipulation and
its tissue regenerative capacity (Poss et al., 2002). Zebrafish
models are directed to observe the cardiomyocyte proliferation
after heart ablation or myocardium crioinjury. Significantly,
the principal limitations of this model is the handling
and HF procedure performing in an aquatic species, the
anatomical differences of cardiovascular system with mammals
and the setting up of imaging techniques for hemodynamic
measurements (González-Rosa et al., 2014). However, the
interspecies jump is too high to conclude the evidence acquired
in zebrafish cardiovascular studies for human ormammal cardiac
diseases. For that purpose, heart regeneration models have been
established in mouse neonates. Obviously, the cardiac repair
differs from zebrafish, but the cardiac insult is quite similar.
Crioinjury infarct and apex ablation are basically the preference
model in this field. Surgical expertise and special handling are
crucial for the success of the technique. The main point in the
surgical part is the promptness to open the chest and damage the
myocardium. The anesthetic regimen is based on the immobility
by cold, which should be recovered as soon as possible. Later,
the most important tour de force is the reinstatement to the
mother due to the easy induction to cannibalism by the extremely
sensitive olfactory and visual sense (Laflamme and Murry, 2011).
While a number of imaging methods and applications have been
shownmainly using optical microscopy, MRI can be adapted and
can provide additional in vivo information (Figure 5).
Atherosclerosis and Vascular Lesion
Characterization
Atherosclerosis is a chronic inflammatory disease, affecting the
medium and large arteries, characterized by the progressive
accumulation of lipid deposits and different cell types in the
subendothelial space (mainly immune cells and vascular smooth
muscle cells) to form the atherosclerotic plaques. The major
clinical manifestations of atherosclerosis are CAD, leading to
acute MI (see Section Imaging in Myocardial Infarction and
Coronary Artery Disease); cerebrovascular disease, leading to
stroke; and peripheral arterial disease, leading to ischemic
limbs and viscera (Libby, 2002). Traditionally, diagnosis of
atherosclerosis was only possible at advanced stages of disease,
either by directly revealing the narrowing of the arterial lumen
(stenosis) or by evaluating the effect of arterial stenosis on
organ perfusion. However, it is now well recognized that the
atherosclerotic plaques responsible for thrombus formation
are not necessarily those that impinge most on the lumen
of the vessel. New imaging approaches allow the assessment
not only of the morphology of blood vessels but also of
the composition of the vessel walls, enabling atherosclerosis-
associated abnormalities in the arteries to be observed, down to
the cellular and molecular level in some cases. Some of these
approaches are now in clinical use or are being tested in clinical
trials, whereas others are better suited for basic and translational
research (Sanz and Fayad, 2008; Owen et al., 2011).
Animal Models of Atherosclerosis
Experimental models of atherosclerosis are required to
understand the natural history of the disease and the factors
leading to plaque progression and rupture. Thus, ideally,
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FIGURE 5 | Representative high resolution MRI sections to visualize the normal heart structure of zebrafish embryo (A) and an adult fish (B). From
Bryson-Richardson et al. (2007) Figure 1 with original publisher’s permission (Bio Med Central).
animal models of atherosclerosis should present a progressive
development of arterial lesions throughout life, from initial fatty
streak to advanced complicated lesions (ulceration, thrombus,
etc. . . ), with shared histological features and clinical events (MI,
stroke) similar to humans (Russell and Proctor, 2006; Fuster
et al., 2012).
Animal models of atherosclerosis started emerging in the
literature at the beginning of the twentieth century with rabbits
being the first animal species to be described (Ignatowski,
1908). Since then, a wide variety of animal models, including
mice, rats, guinea pigs, hamsters, avian, swine, and non-human
primates, have provided valuable information about diagnostic
and therapeutic strategies for atherosclerosis (Xiangdong et al.,
2011; Fuster et al., 2012). Currently, mice, rabbits, and pigs
dominate this field of research. Susceptibility to atherosclerosis
varies not only between animal species but also between genetic
strains within the same species.
The mouse is the most frequently used animal species in
atherosclerosis research. Some of the reasons include low costs,
availability, rapid development of plaque, well-known genome,
possibility of genetic manipulations, and easy usability. But mice
are highly resistant to atherosclerosis as compared to humans,
due in part to amarkedly different lipid profile. Therefore, genetic
variants that do develop the disease have been created either
by spontaneous mutations or by gene manipulation methods.
The majority of mouse models are based on disturbance of
lipid metabolism through genetic manipulation of the C57BL/6
strain. Among those, the apolipoprotein E-deficient mouse
(apoE-KO) is the most distributed worldwide. Arterial lesions
observed in apoE-KO are relatively similar to lesions found
in humans: from foam cell-rich fatty streaks to atherosclerotic
lesions with large necrotic core, and fibro-fatty nodules. In
mice, the most advanced lesions have been described to
occur in the aortic root, aortic arch, and innominate artery
(brachiocephalic trunk), whereas in humans the lesions are
more frequent in the coronary arteries, carotids, and peripheral
vessels, such as the iliac artery (Nakashima et al., 1994). In
addition, most murine models do not manifest the unstable
atherosclerotic plaque with overlying thrombosis, the lesionmost
often associated with clinically significant acute cardiovascular
episodes. This is due to a spontaneous high fibrinolytic activity
in the mouse (Zhu et al., 1999). Moreover, the size of the
arteries makes it extremely difficult to image with sufficient
resolution in clinical scanners used for humans, precluding the
efficient translation of techniques from animal model to human
scanning.
When the size becomes more important, small animal
models need to be complemented by larger animal models in
which vessel characteristics are more similar to human arteries.
Rabbits develop atherosclerotic lesions on a high cholesterol
diet, and have been used extensively in atherosclerosis research
(Yanni, 2004). The most widely used, the New Zealand white
rabbit, develops fatty streaks and intimal thickening when
fed a high cholesterol diet, with most of the lipids localized
within the profuse macrophage-derived foam cells. Lesions are
preferentially localized in the aortic arch and the thoracic aorta.
More advanced lesions can be induced by performing a balloon
injury of the aorta or the carotid artery and further fed with
high fat diet. This combined protocol accelerates the formation
of atherosclerotic lesions and produces plaques that exhibit
a lipid core surrounded by a fibrous cap due to increased
proliferation of vascular smooth muscle cells, thus resembling
more closely human advanced plaques (Badimon, 2001). Like
mice, some rabbit strains carry genetic mutations that lead to
hyperlipidemia and atherosclerosis, with the Watanabe heritable
hyperlipidemic rabbit being the most commonly used; these
animals spontaneously develop lesions due to an inactivating
mutation in the gene encoding the LDL receptor (Watanabe,
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1980). In these animals the atherosclerosis progresses with age
even with a cholesterol-free diet.
Onemajor advantage of the rabbit model is the relatively small
animal size, which makes it easy to care, handle and feed, and
therefore inexpensive, but large enough to monitor physiological
changes and use clinical scanners. Rabbits are favored when
imaging arteries; the diameter of the rabbit aorta is 2–4mm,
comparable to the size of human coronary arteries. Imaging
techniques such as ultrasound or MRI can be effectively applied
to determine the plaque composition and its vulnerability (Helft
et al., 2002; Wetterholm et al., 2007; Phinikaridou et al., 2010).
The major disadvantage of this model is the relatively slow
progression of the pathological condition and the required length
of the studies.
However, when trying to obtain close-to-clinical models,
pigs and minipigs seem to be the most representative ones.
Pigs have a highly comparable anatomy and physiology of
the coronary system with humans (White et al., 1986), as
well as a very similar lipoprotein profile and metabolism
(Dixon et al., 1999). Unlike mice and rabbits, pigs develop
spontaneous atherosclerosis during aging, and the development
of plaques can be induced by diet, hyperglycemia and by
introducing vascular injury, usually by angioplasty. In addition,
with use of toxin-mediated pancreatic damage and a high
fat diet, human diabetes mellitus-like metabolic alterations
will develop, followed by coronary lesions resembling the
human condition closely, with even some characteristics of
vulnerable plaque (Gerrity et al., 2001). Also, porcine models of
familial hypercholesterolemia based on delayed LDL clearance
have been shown to develop complex atherosclerotic lesions.
The lesions are preferentially localized in the aorta, coronary
and iliac arteries, and are characterized by necrotic cores,
calcification, neovascularization and intraplaque hemorrhage,
closely mimicking advanced human plaques (Prescott et al.,
1991). However, the size and composition of the LDL differ in
the high-fat diet fed pigs and the familial hypercholesterolemic
pigs (Checovich et al., 1988). Although pigs are an excellent
model for studying the basic mechanisms, pathophysiology, and
progression of atherosclerosis, their high cost ofmaintenance and
longer diet-induction time limit the use of pigs in research of
atherosclerosis on a large scale.
The Imaging Modality of Choice for
Atherosclerosis Assessment
Different non-invasive imaging modalities can provide
information about plaque anatomy and composition.
Nonetheless, post-mortem histological analysis of atherosclerotic
lesions in experimental animal models (and human autopsies)
is fundamental to validate the model and the technique and
remains the gold standard.
Ultrasound imaging can be used for plaque detection and
analysis in animal models of atherosclerosis (e.g., rabbit,
monkey), typically by measuring carotid or aortic wall thickness
using high-frequency ultrasound transducers (Zeng et al.,
2015). Determination of plaque composition with ultrasound is
based on tissue echogenicity: hypoechoic heterogeneous plaque
is associated with both intraplaque hemorrhage and lipids,
whereas hyperechoic homogeneous plaque is mostly fibrous;
however, precise plaque characterization (lipid core, intraplaque
hemorrhage, or fibrous cap rupture) is not possible using
non-invasive ultrasound measurements and image acquisition
is complex and operator dependent. Notably, recent advances
with contrast-enhanced ultrasound based on microbubbles have
allowed detection of plaque neovascularization and disease
progressionmonitoring (Giannarelli et al., 2010; Nitta-Seko et al.,
2010; Tian et al., 2013).
CT is also well suited for studying atherosclerosis non-
invasively in all vascular regions, although it requires the use
of ionizing radiation and contrast agents. The main advantages
of CT include its high spatial resolution and the short scan
times, but its major disadvantage for atherosclerotic plaque
characterization is the limited discrimination of soft tissue.
Although vascular calcification is the main target of this
imaging modality, CT can also provide reasonably accurate
quantification of plaque size and crude characterization of plaque
composition on the basis of lipid-rich tissue attenuating X-rays
to a smaller extent than fibrous tissue (Viles-Gonzalez et al.,
2004; Cordeiro and Lima, 2006). The development of micro-
and nano-CT has allowed higher spatial resolution, enabling
in vivo and ex vivo studies in small animal models (Awan
et al., 2011). CT imaging can also be merged with positron
emission tomographic (PET) modalities, most prominently with
18F-fluorodeoxyglucose (18F-FDG), to study the metabolic state
of the vascular lesion in addition to its anatomical features (Vucic
et al., 2011).
MRI can provide information on both plaque burden and
composition in multiple arterial territories. Compared with
other imaging modalities, MRI appears to have the greatest
potential for plaque characterization. Based on differences in
the biophysical and biochemical properties of the different
components of the plaque, it is possible to determine the
anatomy and composition of the lesions (lipid-rich necrotic
core, fibrous cap, calcification, fibrosis) by combining multiple
contrast sequences (T1, T2, and proton-density weightings; Corti
and Fuster, 2011). Vulnerability criteria such as ulceration, cap
rupture and intraplaque hemorrhage are also easily identifiable.
The main advantages of MRI include its high spatial resolution,
great soft-tissue contrast, lack of radiation exposure and
good clinical translatability. Several studies have validated the
feasibility of high resolution MRI to quantify atherosclerosis
progression/regression and to determine composition of
atherosclerotic lesions in animal models, including mouse
(Fayad et al., 1998), rabbit (Helft et al., 2001; Ibanez et al., 2012),
and pig (Worthley et al., 2000). Figure 6 shows an example
of in vivo MRI plaque characterization of rabbit abdominal
aorta. Furthermore, use of contrast agents such as gadolinium
(Koktzoglou et al., 2006) or ultrasmall paramagnetic iron-oxide
particles (Millon et al., 2013) and the possibility of combination
with PET (Davies et al., 2005; Millon et al., 2013) can provide
information on the inflammatory activity and the presence
of macrophages in the plaque. Thus, MRI is an excellent
imaging modality to monitor atherosclerotic plaque formation
and destabilization in preclinical animal models. Multimodal
molecular imaging approaches such as PET/CT, PET/MRI,
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FIGURE 6 | T2-Weighted (T2W) (A) and Proton Density (PD) in vivo MR
image (B) of a rabbit abdominal aorta with advanced atherosclerosis.
(C) Corresponding histopathological section with Masson’s trichrome elastin
stain showing fibrotic and lipid components and magnification (D) showing the
foam cell-rich lipid regions and the fibrotic cap. Taken from Helft et al. (2001)
with permission.
MRI-optical, and PET-optical focuses in identifying cellular
and molecular targets (e.g., dysfunctional endothelium, mineral
deposition, enzymatic activity, inflammation, neovascularization,
thrombosis, extracellular matrix production, etc. . . ), and is
playing a role in understanding these key biological processes
of atherogenesis in vivo. The use of coordination chemistry
(including various chelates depending on the final application)
or colloidal chemistry including metallic nanoparticles or
nanosystems such as biocompatible polymers or liposomes,
modified or coated with peptides, proteins or antibodies for
increasing in vivo specificity and target specific molecules. One
very recurrent demonstration is the imaging of the vascular cell
adhesion molecule (VCAM-1) for what different radiolabeled
ligands (Nahrendorf et al., 2009) or nanoparticles functionalized
with different molecules have been tested (Kelly et al., 2005;
Nahrendorf et al., 2006; Broisat et al., 2012; Michalska et al.,
2012). In the road for translation, it is especially relevant the
role of different animal models. There are many examples in the
bibliography and excellent reviews are continuously covering
these new aspects (Nahrendorf et al., 2009; Mulder et al.,
2014). These advances are also relevant in other cardiovascular
conditions, but for the sake of simplicity we are not covering
them.
In addition to the aforementioned non-invasive techniques,
optical coherence tomography (OCT), a novel invasive catheter-
based technology, has gained much interest as a preclinical tool
for plaque characterization. OCT is analogous to ultrasound,
measuring the back-reflection of infrared light rather than sound.
OCT generates high-resolution (5–20µm) three-dimensional
images with high data acquisition rates and small and inexpensive
guidewires/catheters. Its main drawback is the limited tissue
penetration (1–3mm; Stamper et al., 2006).
Animal Models for Pulmonary
Hypertension Image Studies
Animal models are indispensable for the advance of imaging in
PH. In this disease imaging tools have helped to the mechanistic
understanding of PH evaluating pulmonary vasculature and RV
function and allowing identification of innovative biomarkers.
It is important to recognize that PH accomplish different
conditions that finally share a common finding, the chronic
increase in pulmonary artery pressure. The conditions that lead
to the development of PH are grouped according to the Nice
Classification (Simonneau et al., 2013). At the time we need
to choose an animal model, this should fit: (a) the primary
change that is related with the specific PH that we want to study
and (b) the functional and structural changes that occurs in
cardiovascular system as consequence of the disease.
Special attention deserves the RV as this is the major
determinant of functional state and prognosis in PH (Ryan
and Archer, 2014). Usually when RV failure is late diagnosed,
patient mortality in a short term and worsening quality of life
are increased. In this way, implementation of imaging tools in
animal models can be used for detection of early changes in RV
and pulmonary vessel function that could bemodified preventing
worsening and failure.
Echocardiography is probably the most extendedly used
imaging tool in PH in both, clinical practice and animal studies.
An estimation of the pulmonary artery pressure can be done
using a modified Bernoulli equation. Doppler echocardiography
provides a non-invasive assessment of the RV structure and
function, and it is used to monitor progression and response to
therapy. The interval between the onset of flow and peak flow
of the pulmonary artery (pulmonary artery acceleration time) is
inversely related with pulmonary artery pressure and can be used
to estimate the severity of PH (Figure 7).
MRI is becoming the gold standard in the study of patients
with PH and also its application in animal studies is increasing.
MRI facilitates a well-detailed anatomical description of RV.
UsingMRI important advances have been done in the description
of flow in 2D and 3D (4D) bringing new insights related
with functional hemodynamic changes during PH. MRI allows
the simultaneous measurement of pulmonary artery area and
flow velocity allowing complex hemodynamic assessment. This
assessment includes the calculus of wave speed and the evaluation
of wave reflection phenomena. Also, PA distensibility can be
estimated by area changes in PA.
CT can be a diagnostic and also a complimentary tool
in PH. It is nowadays the reference tool for diagnosis of
pulmonary embolism, which is involved in the etiology of
chronic thromboembolic PH. CT provides unbeaten structural
information of the lungs which is essential to reveal the
direct relation between lung parenchyma and pulmonary
vessels.
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FIGURE 7 | Representative echocardiography (A), MRI (B) pulmonary artery flow in controls and experimental rats with moderate and severe
pulmonary hypertension. VTI, velocity time integral; PAAT, pulmonary artery acceleration time; SV, stroke volume; CO, cardiac output. Modified from Urboniene
et al. (2010) Figure 2 with permission.
PET is less used in clinical practice and is not a routine tool for
the evaluation of PH patients. However, new mechanistic insides
are described due to its ability of tracking complex process such
as cellular proliferation, metabolic pathways, inflammation, and
ventilation/perfusion distribution. These processes can be critical
in the understanding of PH physiopathology and can also be used
in the near future for patient follow-up and therapeutic targeting.
All this has made PET a promising field for new animal and
clinical studies.
No animal model is perfect in any of the PH types. This is
due to the complex changes related with vessel remodeling, which
involve different molecular and cellular pathways and depend
on multiple variables. Models that combine multiple insults
yield more severe PH with better hemodynamic and histological
fidelity to human pathology. However, animal models can
represent specific changes that can be studied. Given this, we can
describe the different animal models used in PH as follows:
- An increase in the pulmonary vasomotor tone caused
by hypoxia. This model resembles pulmonary arterial
hypertension (Group 1 of the Nice classification). Hypoxia
can be created in a normobaric or hypobaric environment.
This model is used in small animal, as the animal should be
enclosed in the hypoxic environment. Rats exposed to this
model show a decrease in blood flow velocity measured by
dynamic MRI (de La Roque et al., 2011). Novel experimental
treatments for PH have been tested using this model. For
example, treatment with dehydroepiandrosterone improves
the right ventricular systolic and diastolic functions assessed by
Doppler echocardiography (Dumas de La Roque et al., 2012).
Although causing an elevation in pulmonary artery pressure,
chronic hypoxia is associated with minimal vascular remodeling,
which limits its use (Ciuclan et al., 2011). More recently, vascular
endothelial growth factor receptor (VEGF-R) blockade with the
tyrosine kinase inhibitor SU5416 have been introduced and the
SU5416 plus chronic hypoxia model is now being extensively
used (de Raaf et al., 2014). This model features angio-obliterative
PH resembling human pulmonary arterial hypertension and
also increases RV pressure and RV hypertrophy comparing
to mice just submitted to chronic hypoxia (Ciuclan et al.,
2011). Dehydroepiandrosterone was also tested in this model.
Echocardiography data showed that this drug significantly
reduced RV internal diameter during diastole and restored the
normal position and orientation of the interventricular septum,
which had been otherwise flattened (Alzoubi et al., 2013).
- Endothelial damage produced by monocrotaline. This
model also resembles Group 1 of the Nice Classification.
Monocrotaline elicits pulmonary arterial endothelial cells
dysfunction on multiple levels but is characterized by
pulmonary artery arterial medial hypertrophy and not by
endothelial cell-mediated angioobliteration (the last is present
in the human disease and in the SU5416/hypoxia model).
Monocrotaline has been well described to produce RV
failure, however is criticized because it does not produce
plexogenic arteriopathy, but produces left and RV myocarditis
(Gomez-Arroyo et al., 2012). Using FDG PET authors have
shown an increase in glucose uptake during compensated
RV hypertrophy, which was reversed during decompensated
RV hypertrophy (Sutendra et al., 2013). This behavior was
paralleled by activated hypoxia-inducible factor 1 α (HIF1α)
and angiogenesis evaluated by means of lectin imaging in vivo
(Sutendra et al., 2013). Several proposed treatments have been
evaluated in this model. Using echocardiography, sildenafil,
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pimobendam (a calcium sensitizer and phosphodiesterase
inhibitor) and nicorandil (a vasodilator) were tested. The
2D mode in echocardiography and tissue Doppler imaging
data indicated improved cardiac morphology and function in
all treatment groups (Nakata et al., 2015). Authors showed
that Carvedilol improves fibrosis and hemodynamic behavior
despite persistent RV increased afterload. Carvedilol improved
tricuspid annular displacement and global LV radial and RV
longitudinal strain (Okumura et al., 2015). Other investigators
tested Macitentan therapy showing an increase in pulmonary
artery acceleration time and a decreased deceleration time and
decreased RV wall thickness with this therapy (Temple et al.,
2014).
- Decrease in the total vessel area produced by clots or beads
injection. These models resemble chronic thromboembolic
PH (Group 4 of the Nice classification). An increase in
pulmonary artery pressure and resistance as well as signs of
RV remodeling have been described after repeated injections
of beads. Different protocols of injection has been tested
to find an important increase in pulmonary artery pressure
and resistance without causing death of the animal. Using
microbeads injection in dogs authors have demonstrated that
both magnitude and flow-sensitive data from a single 4D flow
CMR acquisition permit simultaneous quantification of cardiac
function and cardiopulmonary hemodynamic parameters
important in the assessment of PH (Roldán-Alzate et al., 2014).
The same authors demonstrated the benefit of using the same
sequence for measuring cardiac chamber volumes and flow
resulting in an overall shortened examination acquisition time
(Roldán-Alzate et al., 2014).
- Increase in the pulmonary artery flow produced by shunt. The
mechanisms of PH with left-to-right shunt are different from
those of hypoxia and inflammation. Possible inciting factors
of the former are mechanical stretch and shear stress. MRI
was evaluated in rats with aortocaval shunt to reliably produce
right ventricular volume overload and secondary PH. Due to
a combination of left ventricular dysfunction and pulmonary
overflow, the PH produced show features similar to those
found in patients with chronic atrial-level shunt. The RV end-
diastolic area and the thickness of the RV free wall increased
significantly and a mesosystolic notch was demonstrated in the
Doppler wave profile of the pulmonary flow after 20 weeks of
shunt (Linardi et al., 2014).
- Pulmonary vessels (artery or vein) decrease in compliance
and increase in resistance produced by banding. These models
resemble PH due to left heart disease (Group 2 of the Nice
Classification). Selecting artery or vein a model of pre or
post-capillary PH can be developed. A porcine model of
postcapillary PH by non-restrictive banding of the confluent
of both inferior pulmonary veins was developed and evaluated
(Pereda et al., 2014). All banded animals developed PH.
Ventricular remodeling produced progressive increase in end
diastolic and systolic volumes of the RV, an increase in its mass,
and an EF decrease. Also this model consistently reproduced
most pathology changes usually seen on pulmonary arterial
circulation, including intimal fibrosis (Pereda et al., 2014). In
a precapillary PH model by pulmonary artery banding, early
compensatory mechanisms of the RA and RV response to
RV pressure overload were investigated (Voeller et al., 2011).
In this study, MRI with tissue tagging was used to measure
circumferential and minimum principle strain. The resulting
data revealed that early RV pressure overload, without chamber
enlargement, has a measurable effect on RA function and RV
strain patterns when overload is severe. With a 2.5-fold rise
in RV afterload, RV filling became more dependent on RA
conduit than reservoir function, which likely reflects loss of RV
diastolic compliance and consequent stiffening of the RA and
RV walls (Voeller et al., 2011).
- In some studies, authors have combined different models of
PH. For example, using the monocrotaline plus pulmonary
artery banding, the inhibition of pyruvate dehydrogenase
kinase by dichloroacetate on RV hypertrophy was evaluated
(Piao et al., 2010). The rationale for combining two models
was that in the monocrotaline model, there is an intrinsic
coupling between severity of RV hypertrophy and severity
of the pulmonary vascular disease, while pulmonary artery
banding results in RV hypertrophy secondary to pure pressure
overload. The study was performed by echocardiography
and PET. FDG uptake in RV and the RV/LV FDG was
increased in monocrotaline and pulmonary artery banded rats.
Dichloroacetate tended to reduce FDG uptake ratio and also
improved the pulmonary artery acceleration time (Piao et al.,
2010).
A recent report includes three different models (one acute and
two chronic) of PH and one vasodilator testing to validate
a CMR estimation of pulmonary vascular resistance (García-
Álvarez et al., 2013). Acute and chronic beads embolization
and pulmonary vein banding were used as models of PH. They
showed that changes in pulmonary artery velocity inversely
correlate with pulmonary vascular resistance and that MRI can
be used to track acute and chronic in PVR (García-Álvarez et al.,
2013).
Cardiovascular Imaging for Translational
Research
Nowadays, we have the possibility of using in animal research
the same cardiovascular imaging technology used for human
diagnosis to establish the severity and prognosis of diseases.
Imaging systems and methods previously described provide
a common link between humans and experimental animal
models for identifying common phenotypes of cardiovascular
diseases in their functional and morphological aspects. Tissue
characterization by MRI in the evaluation of necrosis, fibrosis,
fat, perfusion, flow, and myocardial edema and in the evaluation
of cardiovascular pathologies is one of the vanguard tools
for clinical and translational research. Nuclear medicine based
techniques for molecular imaging using PET or SPECT for
myocardial metabolic and perfusion characterization have been
used for years. PET is currently used for human atherosclerosis
and FDG PET has recently gained a role in the assessment
of patients with PH. Due to the high sensitivity of these
nuclear medicine based protocols, applications are surely in a
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prominent position to investigate novel metabolic and cellular
targets in animal models with potential human translation.
Similar or alternative molecular procedures for MRI are
based in Gadolinium, Fluorine, iron oxide nanoparticles, and
recently in hyperpolarization procedures (Schroeder et al., 2008;
Bhattacharya et al., 2009; Rider and Tyler, 2013). Despite
the many examples targeting multiple molecular and cellular
pathways in animal models, the reduced sensitivity of MRI
probably hampers its further development on translational
research. However, cardiovascular hybrid imaging includingMRI
technology are leading tools for new translational research, since
they provide simultaneous or sequential acquisitions covering
molecular, functional, cellular and tissue characterization of
different cardiovascular disease phenotypes.
Conclusions
Imaging technologies for the study of cardiovascular diseases
are in constant progress and their relevance in the guidance
of patients will probably expand in the next years. Specific
structural, functional and molecular changes will be surely
be observed by imaging technologies. In this process, the
discovery of new pathophysiological pathways will bring
new approaches for both diagnostic and therapeutics targets.
This growth will also generate new hypotheses and original
research lines will consequently emerge. During this phase,
any innovative imaging technology will require to be tested
in specific disease mimicking malignant conditions and new
imaging tracers to study particular molecular and physiological
changes will also be evaluated using imaging methodologies.
All these examples will always require the optimization of
animal models trying to find a better approach to the human
disease.
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